良性前列腺增生:快速证据综述
本文综述良性前列腺增生所致下尿路症状的评估与治疗。症状影响25%美国男性,近半数至少中度。评估聚焦症状严重程度,治疗以改善症状为目标。α受体阻滞剂或PDE5抑制剂为一线,前列腺体积≥30 mL可加5α还原酶抑制剂,仅1%需手术。
要点
- 直肠指检评估前列腺体积准确性有限,启动5α还原酶抑制剂或考虑手术时优选经直肠超声验证。
- 不推荐常规行血清PSA检测评估下尿路症状,癌症筛查需共享决策。
- α受体阻滞剂起效快可用于急性尿潴留,与PDE5抑制剂联用无额外获益。
核心结论
- 良性前列腺增生下尿路症状的评估应聚焦症状严重程度,治疗以改善症状为目标,多数患者无需手术。
研究设计与样本
- 本文为快速证据综述,总结良性前列腺增生下尿路症状的评估与治疗证据。
主要发现
- 下尿路症状影响25%美国男性,近半数至少中度症状;久坐、高血压和糖尿病增加症状风险。
- 国际前列腺症状评分是追踪症状的最佳方式。
- 锯棕榈无效,非洲臀果木和β-谷甾醇可能有效。
- α受体阻滞剂起效快可用于急性尿潴留,与PDE5抑制剂联用无获益。
- 仅1%下尿路症状患者需要手术,经尿道前列腺电切术改善症状但多种微创选项可选。
关键数值与推荐
- 经直肠超声显示前列腺体积≥30 mL且症状未控制时,应启动5α还原酶抑制剂。
- 5α还原酶抑制剂需长达一年才完全起效,与α受体阻滞剂联用更有效。
- 不推荐常规血清PSA检测评估下尿路症状,癌症筛查需共享决策。
临床怎么用
- 用国际前列腺症状评分追踪症状,首选自我管理(限晚间液体、减少咖啡因酒精、膀胱训练、盆底肌锻炼、正念)。
- 一线药物为α受体阻滞剂或PDE5抑制剂,α受体阻滞剂可用于急性尿潴留。
- 症状未控制且前列腺体积≥30 mL时加用5α还原酶抑制剂,需告知起效需一年。
局限性
- 原文未报告综述的检索范围、纳入研究数量及证据等级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lower urinary tract symptoms from benign prostatic hyperplasia affect 25% of U.S. men, nearly one-half of whom have at least moderate symptoms. Sedentary lifestyle, hypertension, and diabetes mellitus increase risk of symptoms. Evaluation is focused on determining severity of symptoms and therapy to improve symptoms. Rectal examination has limited accuracy in evaluating prostate size. Transrectal ultrasonography is preferred to verify size when starting 5-alpha reductase therapy or considering surgery. Serum prostate-specific antigen testing is not recommended in routine evaluation of lower urinary tract symptoms, and shared decision-making should be used for cancer screening decisions. The International Prostate Symptom Score is the best way to track symptoms. Self-management methods, including limiting evening fluid intake, reducing caffeine and alcohol intake, toilet and bladder training, pelvic floor exercises, and mindfulness techniques, can improve symptoms. Although saw palmetto is not effective, the herbal treatments Pygeum africanum and beta-sitosterol may be effective. Primary medical treatment involves alpha blockers or phosphodiesterase-5 inhibitors. Alpha blockers offer rapid benefit and can be used for acute urinary retention. Combining alpha blockers and phosphodiesterase-5 inhibitors is not beneficial. For uncontrolled symptoms, 5-alpha reductase inhibitors should be started if the prostate volume is 30 mL or greater by ultrasonography. 5-Alpha reductase inhibitors take up to one year to be fully beneficial and are more effective when taken with alpha blockers. Only 1% of patients with lower urinary tract symptoms require surgery. Although transurethral resection of the prostate improves symptoms, many less invasive options with varying effectiveness can be considered.
引用
- Arnold MJ, Gaillardetz A, Ohiokpehai J, et al. Benign Prostatic Hyperplasia: Rapid Evidence Review. Am Fam Physician. 2023. PMID: 37327163
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。